KL-290052

N/A

Report date: 2022/01/17 12:14:22
NME

Base Information

Drug NameKL-290052
Drug Alias NameKL290052胶囊KL290052
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor delta agonists
TargetsPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor delta
Therapy Area/IndicationsCholangitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSichuan Kelun-Biotech Biopharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSichuan Kelun-Biotech Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCholangitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A